The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Pediatric Asthma Treatment Market During The Forecast Period 2026–2030?
The pediatric asthma treatment market size has seen strong growth in recent years. It is forecast to increase from $11.65 billion in 2025 to $12.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.7%. The expansion observed in prior periods can be attributed to factors like the limited availability of pediatric-specific asthma medications, a reliance on hospital-based treatment, the growing prevalence of childhood asthma, increasing awareness among caregivers, and the adoption of conventional inhalers and short-acting beta agonists.
The pediatric asthma treatment market size is projected to experience robust expansion over the coming years. This market is forecast to reach $15.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This anticipated growth is driven by factors such as the advancement of biologics and combination therapies, the incorporation of digital health monitoring devices, an increase in home care service availability, growing adoption of online pharmacies, and more regulatory approvals for pediatric asthma medications. Key trends anticipated during this period encompass a greater embrace of personalized pediatric asthma therapies, heightened utilization of biologic treatments and combination inhalers, an expansion of home care and remote patient monitoring, wider online and retail pharmacy distribution channels, and an emphasis on prompt diagnosis and preventative asthma management.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25868&type=smp
What Underlying Factors Are Accelerating The Growth Of The Pediatric Asthma Treatment Market?
The rising occurrence of respiratory infections is projected to propel the expansion of the pediatric asthma treatment market moving forward. Respiratory infections are described as illnesses caused by viruses, bacteria, or other pathogens affecting the respiratory tract, including the nose, throat, airways, and lungs. The increasing frequency of these infections primarily stems from escalating air pollution, as exposure to pollutants such as particulate matter and nitrogen dioxide weakens the respiratory system, making individuals more vulnerable to infections. Pediatric asthma treatment aids in reducing the frequency and severity of respiratory infections by enhancing airway function and minimizing inflammation, thereby lowering susceptibility to infectious triggers. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, chronic obstructive pulmonary disease contributed to 3.6% of the total disease burden and accounted for 50% of the total burden of respiratory conditions. Hence, the increasing prevalence of respiratory infections drives the growth of the pediatric asthma treatment market.
What Market Segments Are Evaluated Within The Pediatric Asthma Treatment Market?
The pediatric asthma treatment market covered in this report is segmented –
1) By Type: Long-Term Control Medications, Quick-Relief Medications, Other Types
2) By Drug Class: Inhaled Corticosteroids, Long-Acting Beta Agonists, Leukotriene Modifiers, Antihistamines, Biologics
3) By Route Of Administration: Oral Route, Nasal Route, Injectable Route
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Clinics, Home Care, Other End users
Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists, Combination Inhalers, Biologic Therapies
2) By Quick-Relief Medications: Short-Acting Beta Agonists, Anticholinergics, Systemic Corticosteroids
3) By Other Types: Immunotherapy, Methylxanthines, Alternative Therapies
What Industry Trends Are Redefining The Pediatric Asthma Treatment Market?
Leading companies in the pediatric asthma treatment market are concentrating on developing innovative therapies, such as monoclonal antibodies, to address and reduce airway inflammation in children. Monoclonal antibodies are proteins created in laboratories, designed to imitate the immune system’s capability to combat harmful pathogens by specifically targeting certain cells or substances. For instance, in April 2024, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, secured approval from the U.S. Food and Drug Administration for FASENRA (benralizumab) as an add-on maintenance treatment for children aged 6 to 11 years diagnosed with severe asthma characterized by an eosinophilic phenotype. This antibody aims to diminish asthma exacerbations and improve symptom control by targeting and eliminating eosinophils. Fasenra is administered via subcutaneous injection once every 4 weeks for the first three doses, subsequently followed by once every 8 weeks, with pediatric dosing adjusted based on body weight.
Who Are The Top Market Participants Influencing The Pediatric Asthma Treatment Market?
Major companies operating in the pediatric asthma treatment market are Pfizer Inc., Merck And Co Inc., Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy’s Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd.
Read the full pediatric asthma treatment market report here:
https://www.thebusinessresearchcompany.com/report/pediatric-asthma-treatment-global-market-report
Which Region Is Projected To Dominate The Pediatric Asthma Treatment Market During The Forecast Period?
North America was the largest region in the pediatric asthma treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric asthma treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pediatric Asthma Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25868&type=smp
Browse Through More Reports Similar to the Global Pediatric Asthma Treatment Market 2026, By The Business Research Company
Asthma Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report
Anti Asthmatics And Copd Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market
Anti Asthmatics And Copd Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model